Clinical Trial Update: MRI to Characterize and Predict CF Liver Disease in PUSH Cohort

View source ↗

Summary

A completed MRI-based study in the PUSH cohort aims to characterize and predict cystic fibrosis-related liver disease and touches on pancreatic insufficiency.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Cystic Fibrosis Liver Disease
• Pancreatic Insufficiency

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Cystic Fibrosis Liver Disease, Pancreatic Insufficiency | Status: COMPLETED